Hengrui Pharma shares rise as Novo Nordisk signs $2.6 billion drug deal

🌐 Investing.com (Cyprus) —
Hengrui Pharma shares rise as Novo Nordisk signs $2.6 billion drug deal

AI Summary

Hengrui Pharma shares rose after Novo Nordisk signed a drug deal valued at $2.6 billion. The headline does not specify the medicines, agreement terms, or expected financial impact.

Markets Deals Health Hengrui Pharma Novo Nordisk drug deal pharmaceuticals shares $2.6 billion

Read original source →